California company acquires Columbia-based ABC Laboratories
COLUMBIA - A California-based company announced Thursday it acquired Columbia-based Analytical Bio-Chemistry Laboratories, Inc. (ABC Laboratories).
ABC provides product development and analytical testing services to the agrochemical and pharma/biopharma markets. EAG said in a news release its acquisition of ABC will strengthen its laboratories for analytical and testing services for clients in agrochemicals, pharmaceuticals and industrial chemicals.
John Bucksath, CEO of ABC, said, "In EAG, we have aligned with a great partner that has made a strong commitment to our team going forward. Both of our companies have prioritized cultures of scientific excellence and a client-first mindset. EAG has considerable resources, vision and interest in growing its presence in both the agrochemicals and life sciences markets, and we are confident that, as part of EAG, ABC will be even better positioned in the marketplace to broaden its service offerings and capabilities. We all look forward to continuing to grow our business with a very strong partner."
Dr. Siddhartha Kadia, CEO of EAG, said, "ABC has built a very strong reputation with both agrochemical and pharmaceutical clients, and is a strong complementary fit with our business. As government regulations continue to evolve, our clients seek partners with broad capabilities to provide a full suite of laboratory testing services. The combination of the EAG ChemEco and ABC businesses will provide an unparalleled capacity for scientific studies."
EAG has an international network of laboratories, employing 800 people. The company serves more than 5,500 customers worldwide. The company is owned by Odyssey Investment Partners, LLC, a leading private equity firm with more than $3.5 billion in capital.
ABC employs more than 430 people. The company helps manage programs for various drugs, medical devices and drug-device combination products, and agricultural chemicals.